Literature DB >> 29180443

Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice.

Xinzhi Li1, Liudmila L Mazaleuskaya2, Laurel L Ballantyne1, Hu Meng2, Garret A FitzGerald2, Colin D Funk3.   

Abstract

Both cyclooxygenase (COX)-1 and COX-2, encoded by Ptgs1 and Ptgs2, function coordinately during inflammation. But the relative contributions and compensations of COX-1 and COX-2 to inflammatory responses remain unanswered. We used three engineered mouse lines where the Ptgs1 and Ptgs2 genes substitute for one another to discriminate the distinct roles and interchangeability of COX isoforms during systemic inflammation. In macrophages, kidneys, and lungs, "flipped" Ptgs genes generate a "reversed" COX expression pattern, where the knock-in COX-2 is expressed constitutively and the knock-in COX-1 is lipopolysaccharide inducible. A panel of eicosanoids detected in serum and kidney demonstrates that prostaglandin (PG) biosynthesis requires native COX-1 and cannot be rescued by the knock-in COX-2. Our data further reveal preferential compensation of COX isoforms for prostanoid production in macrophages and throughout the body, as reflected by urinary PG metabolites. NanoString analysis indicates that inflammatory networks can be maintained by isoform substitution in inflamed macrophages. However, COX-1>COX-2 macrophages show reduced activation of inflammatory signaling pathways, indicating that COX-1 may be replaced by COX-2 within this complex milieu, but not vice versa. Collectively, each COX isoform plays a distinct role subject to subcellular environment and tissue/cell-specific conditions, leading to subtle compensatory differences during systemic inflammation.
Copyright © 2018 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  animal model; cyclooxygenase; eicosanoid; lipopolysaccharide; macrophage; prostaglandin, gene targeting

Mesh:

Substances:

Year:  2017        PMID: 29180443      PMCID: PMC5748501          DOI: 10.1194/jlr.M080028

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  58 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality.

Authors:  Ying Yu; Jinjin Fan; Yiqun Hui; Carol A Rouzer; Lawrence J Marnett; Andres J Klein-Szanto; Garret A FitzGerald; Colin D Funk
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

3.  Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.

Authors:  Myeong Sup Lee; Byungil Kim; Sun-Min Lee; Woo-Cheul Cho; Wook-Bin Lee; Ji-Seon Kang; Un Yung Choi; Jaemyun Lyu; Young-Joon Kim
Journal:  Mol Cells       Date:  2013-05-10       Impact factor: 5.034

4.  Bioactive products formed in humans from fish oils.

Authors:  Carsten Skarke; Naji Alamuddin; John A Lawson; Xuanwen Li; Jane F Ferguson; Muredach P Reilly; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2015-07-15       Impact factor: 5.922

Review 5.  Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2.

Authors:  Charles D Loftin; Howard F Tiano; Robert Langenbach
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

6.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

Authors:  J E Dinchuk; B D Car; R J Focht; J J Johnston; B D Jaffee; M B Covington; N R Contel; V M Eng; R J Collins; P M Czerniak
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

7.  Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death.

Authors:  Kuniaki Ejima; Matthew D Layne; Irvith M Carvajal; Patricia A Kritek; Rebecca M Baron; Yen-Hsu Chen; Jeffrey Vom Saal; Bruce D Levy; Shaw-Fang Yet; Mark A Perrella
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

8.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

Authors:  R Langenbach; S G Morham; H F Tiano; C D Loftin; B I Ghanayem; P C Chulada; J F Mahler; C A Lee; E H Goulding; K D Kluckman; H S Kim; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

9.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

10.  Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1.

Authors:  Francesca Rauzi; Nicholas S Kirkby; Matthew L Edin; James Whiteford; Darryl C Zeldin; Jane A Mitchell; Timothy D Warner
Journal:  FASEB J       Date:  2016-09-15       Impact factor: 5.191

View more
  8 in total

1.  Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Chong Yuan; Laurel L Ballantyne; Hu Meng; William L Smith; Garret A FitzGerald; Colin D Funk
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

2.  Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Laurel L Ballantyne; Hu Meng; Garret A FitzGerald; Colin D Funk
Journal:  FASEB J       Date:  2018-04-20       Impact factor: 5.191

3.  Increased COX-1 expression in benign prostate epithelial cells is triggered by mitochondrial dysfunction.

Authors:  Chandler N Hudson; Kai He; Laura E Pascal; Teresa Liu; Livianna K Myklebust; Rajiv Dhir; Pooja Srivastava; Naoki Yoshimura; Zhou Wang; William A Ricke; Donald B DeFranco
Journal:  Am J Clin Exp Urol       Date:  2022-08-15

4.  Network pharmacology and in vivo experiments reveal the pharmacological effects and molecular mechanisms of Simiao Powder in prevention and treatment for gout.

Authors:  Huachong Xu; Jialin Wu; Shiqi Wang; Lu Xu; Pei Liu; Yucong Shi; Sizhi Wu; Li Deng; Xiaoyin Chen
Journal:  BMC Complement Med Ther       Date:  2022-06-07

5.  Synthesis, Inhibitory Activity, and In Silico Modeling of Selective COX-1 Inhibitors with a Quinazoline Core.

Authors:  Marcela Dvorakova; Lenka Langhansova; Veronika Temml; Antonio Pavicic; Tomas Vanek; Premysl Landa
Journal:  ACS Med Chem Lett       Date:  2021-03-12       Impact factor: 4.345

6.  Signaling Pathways Mediating Bradykinin-Induced Contraction in Murine and Human Detrusor Muscle.

Authors:  Kinga Borsodi; Helga Balla; Péter József Molnár; Ádám Lénárt; István Kenessey; András Horváth; Attila Keszthelyi; Miklós Romics; Attila Majoros; Péter Nyirády; Stefan Offermanns; Zoltán Benyó
Journal:  Front Med (Lausanne)       Date:  2022-01-20

7.  Isoform-Specific Compensation of Cyclooxygenase (Ptgs) Genes during Implantation and Late-Stage Pregnancy.

Authors:  Xinzhi Li; Laurel L Ballantyne; Mackenzie C Crawford; Garret A FitzGerald; Colin D Funk
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

8.  Deciphering the Active Compounds and Mechanisms of Qixuehe Capsule on Qi Stagnation and Blood Stasis Syndrome: A Network Pharmacology Study.

Authors:  Yu-Xi Huang; Ding-Qiao Xu; Shi-Jun Yue; Yan-Yan Chen; Hui-Juan Tao; Rui-Jia Fu; Li-Ming Xing; Taiyi Wang; Yu-Ling Ma; Bao-An Wang; Yu-Ping Tang; Jin-Ao Duan
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-27       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.